Codex update
This article was originally published in The Tan Sheet
Executive Summary
The Codex Committee of General Principles decides April 3 in Paris not to include the precautionary principle in Codex's draft risk analysis standards for food safety. The principle allows "governments to take certain preventive measures for foods in cases where scientific evidence on the safety of the food is uncertain," says the International Alliance of Dietary Supplement-Food Association. By excluding the principle, a "fair opportunity" is assured for trade in supplement products, says the Council for Responsible Nutrition. The principle's inclusion has been discussed before (1"The Tan Sheet" Oct. 31, 2005, p. 11). IADSA says Codex is at an intermediate stage and attempts could come to include the principle during the next commission meeting later this year...
You may also be interested in...
Trade Groups Push For Codex Health Claims Scientific Basis Guidelines
CRN's John Hathcock, PhD, urged the U.S. and other delegations to Codex's nutrition committee to "move forward" with the "Guidelines on the Scientific Basis of Health Claims" at an Oct. 18 public meeting
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.